Development and initial validation of an updated version of the British Isles Lupus Assessment Groups disease activity index for patients with systemic lupus erythematosus
For Canadian researchers, the practical takeaways: AOD-9604 isolates lipolytic activity without engaging GH receptors or affecting IGF-1 Tesamorelin activates the full GH axis through pituitary release of endogenous GH Both have substantive published research bases with different shapes Choice depends on whether isolated vs full-axis GH biology effects are the research goal Same quality framework Janoshik third-party testing applies to both For continued reading, see What Is AOD-9604
For more details, visit and read our latest blog post: IMPORTANT NOTICE: NC Medicaid Changes Coverage for Certain Weight Management Medications #NCMedicaid #WeightManagement #Zepbound #Wegovy #Saxenda #HealthcareUpdates #PharmacySupport #CommunityHealth #AdvanceCares #AdvanceCommunityHealth NC Medicaid updates coverage for weight management meds IMPORTANT NOTICE: NC Medicaid has updated coverage rules for certain weight management medications, including: Zepbound Wegovy Saxenda For those receiving Wegovy and Zepbound, providers will need to obtain a prior authorization for medication to be covered, but Saxenda will no longer be covered for any indications
Women who notice vaginal dryness, irritation, or recurrent infections during rapid weight loss should discuss hormonal evaluation with their healthcare provider
Industry insiders and the general public often describe these drugs as blockbuster diabetes and weight loss drugs
Mechanism: By reducing oxidative stress in the endothelium (blood vessel lining) and normalizing lipid metabolism
